Journal issues > Issue 2, March 2024 > Impact of treatment delays in patients with head and neck cancer

Impact of treatment delays in patients with head and neck cancer

By: D. Schrijvers MD, PhD, S. Mignon MD, M. Brands MD, S. van Roy MD, S. De Schepper MD, N. Van Bruaene MD, D. Nevens MD, PhD, N. Meireson MD

SUMMARY

Head and neck cancer is a complex cancer that involves multiple disciplines (surgery, radiotherapy, systemic therapy). The timely start of surgery and radiotherapy is of utmost importance since the time between the start of treatment is related to overall survival. A delay in surgery increases overall mortality by 6%, while a delay in radiotherapy increases overall mortality by 9%. In this article, the importance of a short time to start treatment in patients with head and neck cancer is discussed.

(BELG J MED ONCOL 2024;18(2):46–8)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top